http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101258456-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate | 2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101258456-B1 |
| titleOfInvention | Pharmaceutical composition comprising a peptide having leukocyte extravasation inhibitory activity and mast cell degranulation inhibitory activity |
| abstract | The present invention provides a peptide fragment derived from allergin-1, a kind of transmembrane protein, that is, prevention of an inflammatory disease or allergy comprising a peptide consisting of an amino acid sequence of SEQ ID NO: 1 or a peptide consisting of an amino acid sequence of SEQ ID NO: 2 as an active ingredient. Or it provides a pharmaceutical composition for treatment. |
| priorityDate | 2011-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.